Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Clinical mastitis ain't what it used to be
Pam Ruegg
Professor Pam Ruegg speaking at BCVA Congress.
BCVA vets encouraged to keep ahead of the curve on intramammary therapy

"Mastitis today ain't your grandfather's mastitis!" said Professor Pam Ruegg from Wisconsin at the beginning of her presentation entitled 'Treatment of clinical mastitis in lactating cows: new bugs, old drugs and changing expectations' at the BCVA Congress in Hinckley.

Shifting patterns of pathogens during the past few decades mean that current control programmes using intramammary antibiotics may not match the reality of cases on farm. So, for instance, Strep agalactiae infections are now very rare, and the treatment of Staph aureus is a minor aspect of its control.  

The difficulty is that the occurrence of mastitis is based on detection of inflammation not infection. Twenty-five to 40 per cent of cases are culture negative because the cow's immune system has already dealt with the pathogen.

Few mastitis cases are medical emergencies. With this in mind, it is a good idea to encourage farmers to use a simple three-point case assessment score. On average, 85 per cent of cases can be left until a full assessment has been made of the clinical history of the affected cow and bacterial culture. Most of the 'mild' cases are on the way to getting better anyway and there may be benefits to delaying  intramammary infusion and embarking on proper assessment of the cow.

"So can we justify the treatments we use?" asked Prof Ruegg. "The data suggest that in some cases the answer might be 'no'. There is an opportunity to improve our approach. Treatment of cases should be based on the aetiology of the infection and to do this it is useful to have 'on-farm' culture facilities."

Concluding her presentation, Prof Ruegg offered six "take home" points to delegates:

1. Before treatment, check the medical history of the cow. Is she in third lactation or more? There is no evidence that chronic mastitis responds to multiple antibiotic treatments, and in many cases, the milk will return to normal appearance

2. Extended intramammary therapy should be applied to specific cases – only where there is evidence of infection deep in mammary tissue

3. Do not administer antibiotics to cows that do not need it

4. On many farms the use of antibiotics to treat cows with mild E. coli mastitis isn't necessary

5. Develop protocols and monitoring controls

6. Remember, simple symptoms of inflammation do not indicate that antibiotic therapy is necessary. We are always behind the curve and the cow is already trying to cure the infection by the time we see the changes in the milk.

Become a member or log in to add this story to your CPD history

Cold-water dip to raise funds for Vetlife

News Story 1
 The veterinary mental health charity Vetlife is inviting the veterinary community to join it for a sponsored cold-water dip.

The event will take place at Walpole Bay, Margate, on 17 May during Mental Health Awareness Week. Participants of all abilities can join in the challenge and are advised to bring a towel, a hot drink, a snack, and warm clothes to get changed into afterwards.

Those taking part are being asked to try to raise 100 each to support the work of the charity.

Details about how to take part can be found here

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.